Olanzapine and Autism Ranking:

History

Olanzapine was developed and is currently marketed by the pharmaceutical company Eli Lilly and Company. It was approved by the United States Food and Drug Administration (FDA) in 1996 for the treatment of schizophrenia, acute mania in bipolar disorder, agitation associated with schizophrenia and bipolar disorder, and as maintenance treatment in bipolar disorder and psychotic depression.

Updated

17 Jun 2022

Last Review

01 Feb 2016

Next Review

01 Feb 2019